Project Details
Entwicklung neuer rekombinanter Immuntherapeutika für das Hodgkin-Lymphom (T 3)
Subject Area
Medicine
Term
from 1996 to 2002
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 5480850
No abstract available
DFG Programme
Collaborative Research Centres
Subproject of
SFB 502:
Molecular aspects of pathogenesis,diagnostics and therapy of morbus hodgkin and related diseases
Applicant Institution
Universität zu Köln
Project Heads
Professor Dr. Stefan Barth; Professor Dr. Andreas Engert